SecBot SecBot
144 ·Filed Oct 23, 2026

IRD

Opus Genetics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3d 4h ago SEC0001974078-26-000387
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The sale is explicitly for tax withholding on RSU vesting, not a discretionary insider sell signal. Monitor for any subsequent Form 4 filings to confirm the actual sale occurred, but this filing alone is routine and lacks material trading intent.

DirectionNeutral
Confidencehigh
Horizondays

Price Chart

Loading chart...

Executive Summary

Benjamin R. Yerxa, an officer of Opus Genetics, filed a Form 144 notice of intent to sell 33,189 shares of common stock, with an estimated aggregate market value of $117,364.67 based on the filing date price. The sale is described as non-discretionary, required to cover tax obligations related to RSU vesting, which significantly reduces the signaling value of the insider's intent to sell.

Key Facts

  • Benjamin R. Yerxa (Officer) filed Form 144 on 2026-10-23.
  • Proposed sale of 33,189 shares of common stock.
  • Estimated aggregate market value: $117,364.67.
  • Sale is to cover tax obligations from RSU vesting (non-discretionary).
  • Broker: Raymond James & Associates, Inc.
  • Filing date price: $3.54 per share (implied from 33,189 shares / $117,364.67).

Financial Impact

Proposed sale of ~$117K in shares, representing a small fraction of the company's market cap.

dilution

Risk Factors

  • Insider selling for tax purposes is routine but could still pressure the stock if the market interprets it as a lack of confidence.
  • No other material risks identified from this filing.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001974078-26-000387
Document: 0001974078-26-000387-index.html0001974078-26-000387
Document: 0001974078-26-000387.txt0001974078-26-000387
25 reports for IRD
Performance horizon
50% Hit rate @ T+60 2 of 4 directional calls Went positive at some point 5 of 8 best @ T+60▲ +28.19%May 12, 2026
Filters
Rows
Reports for IRD — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
144
NEUTRAL ★ 2/10
$3.52awaiting T+60—$3.47 (−1.42%)
Oct 21, 2026
5d ago
8-K
NEUTRAL ★ 2/10
$3.82awaiting T+60—$3.47 (−9.16%)
Oct 15, 2026
11d ago
8-K
BULLISH ★ 6/10
$3.84awaiting T+60—$3.47 (−9.64%)
Oct 15, 2026
11d ago
Press Release
BULLISH ★ 6/10
$3.84awaiting T+60—$3.47 (−9.64%)
Sep 22, 2026
4w ago
Institutional Cluster
NEUTRAL ★ 3/10
$5.16awaiting T+60—$3.47 (−32.75%)
Sep 11, 2026
6w ago
8-K
BULLISH ★ 7/10
$6.04awaiting T+60—$3.47 (−42.55%)
Sep 9, 2026
6w ago
8-K
BULLISH ★ 7/10
$5.73awaiting T+60—$3.47 (−39.44%)
Sep 2, 2026
7w ago
Press Release
NEUTRAL ★ 5/10
$4.45awaiting T+60—$3.47 (−22.02%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$3.72awaiting T+60—$3.47 (−6.72%)
Jul 23, 2026
13w ago
144
NEUTRAL ★ 2/10
$2.92 $4.05▲ +38.70%▲ +34.15%$3.47 (+18.84%)
Showing 10 of 25

US Market Status

Market Closed — Opens Wed (12h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 23, 2026